Literature DB >> 6428370

The Chestnut Lodge follow-up study. I. Follow-up methodology and study sample.

T H McGlashan.   

Abstract

Chestnut Lodge is a small, private psychiatric hospital in Rockville, Md, specializing in the long-term residential treatment of severely ill (and usually chronic) psychotic and borderline patients. Four hundred forty-six (72%) of the patients treated at Chestnut Lodge between 1950 and 1975 were followed up an average of 15 years later. This first report details the rationale and methods for this investigation.

Entities:  

Mesh:

Year:  1984        PMID: 6428370     DOI: 10.1001/archpsyc.1984.01790170047006

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  12 in total

Review 1.  Recovery in schizophrenia: reality or mere slogan.

Authors:  Natalie B Slopen; Patrick W Corrigan
Journal:  Curr Psychiatry Rep       Date:  2005-08       Impact factor: 5.285

2.  Personality disorder in psychiatric practice.

Authors:  Peter Tyrer; Erik Simonsen
Journal:  World Psychiatry       Date:  2003-02       Impact factor: 49.548

3.  Identifying unmet therapeutic domains in schizophrenia patients: the early contributions of Wayne Fenton from Chestnut Lodge.

Authors:  Thomas H McGlashan; William T Carpenter
Journal:  Schizophr Bull       Date:  2007-07-18       Impact factor: 9.306

4.  Age and mental health services.

Authors:  A V Horwitz; T Uttaro
Journal:  Community Ment Health J       Date:  1998-06

Review 5.  The ESSEN study of childhood-onset schizophrenia: selected results.

Authors:  C Eggers; D Bunk; G Volberg; B Röpcke
Journal:  Eur Child Adolesc Psychiatry       Date:  1999       Impact factor: 4.785

6.  Validity of remission and recovery criteria for schizophrenia and major depression: comparison of the results of two one-year follow-up naturalistic studies.

Authors:  Ilja Spellmann; Rebecca Schennach; Florian Seemüller; Sebastian Meyer; Richard Musil; Markus Jäger; Max Schmauß; Gerd Laux; Herbert Pfeiffer; Dieter Naber; Lutz G Schmidt; Wolfgang Gaebel; Joachim Klosterkötter; Isabella Heuser; Michael Bauer; Mazda Adli; Joachim Zeiler; Wolfram Bender; Klaus-Thomas Kronmüller; Marcus Ising; Peter Brieger; Wolfgang Maier; Matthias R Lemke; Eckart Rüther; Stefan Klingberg; Markus Gastpar; Michael Riedel; Hans-Jürgen Möller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2016-10-26       Impact factor: 5.270

7.  The Munich 15-year follow-up study (MUFUSSAD) on first-hospitalized patients with schizophrenic or affective disorders: comparison of psychopathological and psychosocial course and outcome and prediction of chronicity.

Authors:  Hans-Jürgen Möller; Markus Jäger; Michael Riedel; Michael Obermeier; Anton Strauss; Ronald Bottlender
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2010-05-22       Impact factor: 5.270

Review 8.  Β-Amyloid Burden is Not Associated with Cognitive Impairment in Schizophrenia: A Systematic Review.

Authors:  Jun Ku Chung; Shinichiro Nakajima; Eric Plitman; Yusuke Iwata; Danielle Uy; Philip Gerretsen; Fernando Caravaggio; M Mallar Chakravarty; Ariel Graff-Guerrero
Journal:  Am J Geriatr Psychiatry       Date:  2016-04-29       Impact factor: 4.105

Review 9.  Neurodevelopmental and neurodegenerative models of schizophrenia: white matter at the center stage.

Authors:  Peter Kochunov; L Elliot Hong
Journal:  Schizophr Bull       Date:  2014-05-27       Impact factor: 9.306

10.  Characteristics of hospital-treated schizophrenia in São Paulo, Brazil.

Authors:  P R Menezes; A H Mann
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1993-11       Impact factor: 4.328

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.